U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 050562

Expand all

AZLIN (AZLOCILLIN SODIUM)
EQ 2GM BASE/VIAL
Marketing Status: Discontinued
Active Ingredient: AZLOCILLIN SODIUM
Proprietary Name: AZLIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 2GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N050562
Product Number: 001
Approval Date: Sep 3, 1982
Applicant Holder Full Name: BAYER PHARMACEUTICALS CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information
AZLIN (AZLOCILLIN SODIUM)
EQ 3GM BASE/VIAL
Marketing Status: Discontinued
Active Ingredient: AZLOCILLIN SODIUM
Proprietary Name: AZLIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 3GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N050562
Product Number: 002
Approval Date: Sep 3, 1982
Applicant Holder Full Name: BAYER PHARMACEUTICALS CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information
AZLIN (AZLOCILLIN SODIUM)
EQ 4GM BASE/VIAL
Marketing Status: Discontinued
Active Ingredient: AZLOCILLIN SODIUM
Proprietary Name: AZLIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 4GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N050562
Product Number: 003
Approval Date: Sep 3, 1982
Applicant Holder Full Name: BAYER PHARMACEUTICALS CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top